☆ 4.4 Article

Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screening

RSC MEDICINAL CHEMISTRY (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Development of Highly Potent Noncovalent Inhibitors of SARS- CoV-2 3CLpro

Ningke Hou et al.

Summary: A specific noncovalent inhibitor called WU-04 has been developed, which effectively blocks the replication of SARS-CoV-2 and other coronaviruses. It shows high potency as a pan-inhibitor of coronavirus 3CLpro and has similar activity to the drug Nirmatrelvir in treating SARS-CoV-2.

ACS CENTRAL SCIENCE (2023)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis

Wen Wen et al.

Summary: This study conducted a meta-analysis on three new oral antivirals (molnupiravir, fluvoxamine, and Paxlovid) and their effects on mortality and hospitalization rates among COVID-19 patients. The results showed that these drugs were effective in reducing mortality and hospitalization rates by approximately 67%. Furthermore, the drugs did not increase adverse events, indicating good overall safety.

ANNALS OF MEDICINE (2022)

Add to Collection

Review Medicine, Research & Experimental

RdRp inhibitors and COVID-19: Is molnupiravir a good option?

Seyed Mohammad Reza Hashemian et al.

Summary: Rapid changes in the viral genome allow viruses to evade host immune response, RNA-dependent RNA polymerase is crucial in RNA viral infections. Researchers urgently seek effective treatments for COVID-19, with molnupiravir identified as a potential therapeutic agent.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Add to Collection

Review Infectious Diseases

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review

Thibault Fiolet et al.

Summary: Overall, COVID-19 vaccines have high efficacy against the original strain and variants of concern, with rare serious adverse events. However, prices vary significantly for different vaccines.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Add to Collection

Article Chemistry, Medicinal

Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance

Jiahui Chen et al.

Summary: The Omicron variant of the SARS-CoV-2 virus has caused global panic due to its high infectivity and ability to escape vaccines. A comprehensive analysis using an artificial intelligence model and antibody structure analysis reveals that Omicron may be over 10 times more contagious than the original virus and has an 88% likelihood of vaccine escape. This study highlights the importance of developing mutation-proof vaccines and antibodies.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses

Andreas Luttens et al.

Summary: Developing drug inhibitors targeting SARS-CoV-2 is crucial for saving lives and preparing for future outbreaks. Two virtual screening strategies were explored, resulting in the identification of compounds with inhibitory effects, including one compound with promising antiviral activity.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Nirmatrelvir Plus Ritonavir: First Approval

Yvette N. Lamb

Summary: Nirmatrelvir plus ritonavir is a medication developed for the treatment and post-exposure prophylaxis of COVID-19. It received authorization in the UK and EU for use in adults at high risk for severe COVID-19. Nirmatrelvir is an inhibitor of SARS-CoV-2 main protease, while ritonavir is a protease inhibitor and CYP3A inhibitor.

DRUGS (2022)

Add to Collection

Article Chemistry, Medicinal

Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLPro)

Sang Hoon Han et al.

Summary: Starting from ML300, a structure-based optimization campaign was conducted against the SARS-CoV-2 main protease, resulting in the discovery of compound 41 with antiviral activity. This study provides important insights for the development of antiviral drugs in combating SARS-like coronavirus outbreaks.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CLProtease Inhibitor Clinical Candidate for Treating COVID-19

Yuto Unoh et al.

Summary: S-217622 is the first oral noncovalent, nonpeptidic SARS-CoV-2 3CL protease inhibitor clinical candidate, which could be a potential oral agent for treating COVID-19.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Advances in the Development of SARS-CoV-2 Mpro Inhibitors

Laura Agost-Beltran et al.

Summary: Since the outbreak of COVID-19, scientists have been searching for inhibitors of the main protease (Mpro) of the virus SARS-CoV-2 as potential new drugs. Through the design, synthesis, and testing of two different types of compounds, promising inhibitors have been identified as potential antiviral drugs.

MOLECULES (2022)

Add to Collection

Review Pharmacology & Pharmacy

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

Shenghua Gao et al.

Summary: This article provides a brief overview of medicinal chemistry strategies for the development of effective SARS-CoV-2 inhibitors, highlighting representative examples.

ACTA PHARMACEUTICA SINICA B (2022)

Add to Collection

Article Chemistry, Medicinal

Discovery and Crystallographic Studies of Trisubstituted Piperazine Derivatives as Non-Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity and Low Toxicity

Shenghua Gao et al.

Summary: A potent non-covalent nonpeptide Mpro inhibitor GC-14 has been discovered with high potency against Mpro and excellent antiviral activity, showing low cytotoxicity and excellent target selectivity for SARS-CoV-2 Mpro.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Potential SARS-CoV-2 main protease inhibitors

Riddhidev Banerjee et al.

Summary: This review focuses on recent developments in the search for small-molecule inhibitors targeting the SARS-CoV-2 M-pro, aiming at discovering and designing drugs targeting the key target in the viral replication cycle.

DRUG DISCOVERY TODAY (2021)

Add to Collection

Article Multidisciplinary Sciences

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen et al.

Summary: PF-07321332, an orally bioavailable SARS-CoV-2 main protease inhibitor, has been discovered with in vitro pan-human coronavirus antiviral activity and excellent off-target selectivity and in vivo safety profiles. This new drug has shown promise in countering the threat of COVID-19 with its oral activity and safety in clinical trials.

SCIENCE (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease

Maya G. Deshmukh et al.

Summary: This study optimized an existing FDA-approved chemical scaffold, perampanel, to noncovalently bind and inhibit M-pro, achieving IC(50)s in the low-nanomolar range and EC(50)s in the low-micromolar range. The research presented nine crystal structures of Mpro bound to a series of perampanel analogs, providing detailed structural insights into their mechanism of action and structure-activity relationship. These insights reveal strategies for rational inhibitor design efforts in the context of active-site flexibility and potential resistance mechanisms.

STRUCTURE (2021)

Add to Collection

Article Chemistry, Medicinal

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir

Zilei Xia et al.

Summary: Novel hybrid inhibitors UAWJ9-36-1 and UAWJ9-36-3, designed based on the crystal structure of SARS-CoV-2 M-Pro, showed potent enzymatic inhibition against multiple human coronaviruses. These inhibitors have promising potential as broad-spectrum antivirals against coronaviruses.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Add to Collection

Article Chemistry, Physical

ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution

Chuan Tian et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2020)

Add to Collection

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Add to Collection

Article Chemistry, Medicinal

In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP

Dongwei Kang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Article Multidisciplinary Sciences

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Wayne Vuong et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Chemistry, Medicinal

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors

Chunlong Ma et al.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)

Add to Collection

Article Chemistry, Medicinal

Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds

Pei Liu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Recent applications of click chemistry in drug discovery

Xiangyi Jiang et al.

EXPERT OPINION ON DRUG DISCOVERY (2019)

Add to Collection

Article Chemistry, Medicinal

Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries

Lanlan Jing et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors

Xiangyi Jiang et al.

RSC ADVANCES (2019)

Add to Collection

Article Chemistry, Physical

Building Water Models: A Different Approach

Saeed Izadi et al.

JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2014)

Add to Collection

Article Chemistry, Medicinal

Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes

Richard A. Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Add to Collection

Article Biochemical Research Methods

Automatic atom type and bond type perception in molecular mechanical calculations

Junmei Wang et al.

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)

Add to Collection

Article Chemistry, Medicinal

Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors

Lu Zhou et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Add to Collection

Article Chemistry, Physical

Extension of the MST model to the IEF formalism: HF and B3LYP parametrizations

I Soteras et al.

JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2005)

Add to Collection

Review Chemistry, Physical

MST continuum study of the hydration free energies of monovalent ionic species

C Curutchet et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2005)

Add to Collection

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

RA Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Add to Collection

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

TA Halgren et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Add to Collection

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Add to Collection

Article Chemistry, Physical

Perspective on Density functional thermochemistry. III. The role of exact exchange - Becke AD (1993) J Chem Phys 98:5648-52

K Raghavachari

THEORETICAL CHEMISTRY ACCOUNTS (2000)

Add to Collection

Article Biochemistry & Molecular Biology

The Protein Data Bank

HM Berman et al.

NUCLEIC ACIDS RESEARCH (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.